Preclinical models for evaluating psychedelics in the treatment of major depressive disorder
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander +5 more
wiley +1 more source
Histamine receptor 2 blockade selectively impacts B and T cells in healthy subjects. [PDF]
Meghnem D +4 more
europepmc +1 more source
Development of a Conjugate Vaccine Targeting Human IgE for Long‐Term Prevention of Anaphylaxis
Allergy, EarlyView.
Vincent Serra, Laurent L. Reber
wiley +1 more source
Psilocybin as a novel treatment for chronic pain
Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey +3 more
wiley +1 more source
Histamine Increases Neuronal Excitability and Sensitivity of the Lateral Vestibular Nucleus and Promotes Motor Behaviors via HCN Channel Coupled to H2 Receptor [PDF]
Bin Li +8 more
openalex +1 more source
Psychedelics, entactogens and psychoplastogens for depression and related disorders
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley +1 more source
Regulation of Human Umbilical Artery Contractility By Different Serotonin and Histamine Receptors
António José Santos-Silva +3 more
openalex +2 more sources
Drug Utilization Review of Acid Suppressants (Durable) – an Audit to Assess the Utilization of Proton Pump Inhibitors and Histamine H2-Receptor Antagonists in Canadian Hospitals [PDF]
Alan Barkun, V. Adam, Marc O. Martel
openalex +1 more source

